{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:22:04Z","timestamp":1795112524758,"version":"4.10.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02023-w","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:56:59Z","timestamp":1768377419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Duodenal mucosal intervention in the management of MASLD and type 2 diabetes"],"prefix":"10.1186","volume":"18","author":[{"given":"Zulqarnain","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"1","key":"2023_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039.","journal-title":"J Hepatol"},{"issue":"7","key":"2023_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u201364. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.052.","journal-title":"Gastroenterology"},{"key":"2023_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175597","author":"S Ciardullo","year":"2023","unstructured":"Ciardullo S, Vergani M, Perseghin G. Nonalcoholic fatty liver disease in patients with type 2 diabetes: screening, diagnosis, and treatment. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12175597.","journal-title":"J Clin Med"},{"issue":"4","key":"2023_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021.","journal-title":"J Hepatol"},{"key":"2023_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11020073","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Targher G. Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials. Metabolites. 2021. https:\/\/doi.org\/10.3390\/metabo11020073.","journal-title":"Metabolites"},{"issue":"12","key":"2023_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","volume":"6","author":"RR Mummadi","year":"2008","unstructured":"Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396\u2013402. https:\/\/doi.org\/10.1016\/j.cgh.2008.08.012.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2023_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2018.02.010","volume":"154","author":"ACG van Baar","year":"2018","unstructured":"van Baar ACG, Nieuwdorp M, Holleman F, Soeters MR, Groen AK, Bergman JJGHM. The duodenum harbors a broad untapped therapeutic potential. Gastroenterology. 2018;154(4):773\u20137. https:\/\/doi.org\/10.1053\/j.gastro.2018.02.010.","journal-title":"Gastroenterology"},{"issue":"2","key":"2023_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/gutjnl-2020-323608","volume":"71","author":"G Mingrone","year":"2021","unstructured":"Mingrone G, van Baar AC, Devi\u00e8re J, et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut. 2021;71(2):254\u201364. https:\/\/doi.org\/10.1136\/gutjnl-2020-323608.","journal-title":"Gut"},{"issue":"12","key":"2023_CR9","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.2337\/dc16-0383","volume":"39","author":"H Rajagopalan","year":"2016","unstructured":"Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39(12):2254\u201361. https:\/\/doi.org\/10.2337\/dc16-0383.","journal-title":"Diabetes Care"},{"issue":"5","key":"2023_CR10","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.gie.2024.04.2904","volume":"100","author":"CBE Busch","year":"2024","unstructured":"Busch CBE, Meiring S, van Baar ACG, Holleman F, Nieuwdorp M, Bergman JJGHM. Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study. Gastrointest Endosc. 2024;100(5):896\u2013904. https:\/\/doi.org\/10.1016\/j.gie.2024.04.2904.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"2023_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.orcp.2020.09.001","volume":"14","author":"G Condello","year":"2020","unstructured":"Condello G, Chen CY. Minireview: current status of endoscopic duodenal mucosal resurfacing. Obes Res Clin Pract. 2020;14(6):504\u20137. https:\/\/doi.org\/10.1016\/j.orcp.2020.09.001.","journal-title":"Obes Res Clin Pract"},{"key":"2023_CR12","doi-asserted-by":"publisher","unstructured":"van Baar ACG, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut. 2020(2). https:\/\/doi.org\/10.1136\/gutjnl-2019-318349.","DOI":"10.1136\/gutjnl-2019-318349"},{"issue":"1","key":"2023_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjnph-2024-001006","volume":"8","author":"CBE Busch","year":"2025","unstructured":"Busch CBE, Rubingh J, van Baar ACG, Nieuwdorp M, Bergman J. Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetes. BMJ Nutr Prev Health. 2025;(1):e001006. https:\/\/doi.org\/10.1136\/bmjnph-2024-001006.","journal-title":"BMJ Nutr Prev Health"},{"key":"2023_CR14","doi-asserted-by":"publisher","unstructured":"van Baar ACG, Beuers U, Wong K, et al. Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results. JHEP Rep. 2019(6). https:\/\/doi.org\/10.1016\/j.jhepr.2019.10.006.","DOI":"10.1016\/j.jhepr.2019.10.006"},{"key":"2023_CR15","doi-asserted-by":"publisher","unstructured":"Busch CBE, Meiring S, van Baar ACG, et al. Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study. Gastrointest Endosc. 2024(3). https:\/\/doi.org\/10.1016\/j.gie.2024.01.031.","DOI":"10.1016\/j.gie.2024.01.031"},{"issue":"28","key":"2023_CR16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i28.109468","volume":"31","author":"CJ Fernandez","year":"2025","unstructured":"Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: an emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol. 2025;31(28):109468. https:\/\/doi.org\/10.3748\/wjg.v31.i28.109468.","journal-title":"World J Gastroenterol"},{"key":"2023_CR17","doi-asserted-by":"publisher","unstructured":"Meiring S, van Baar ACG, S\u00f8rensen N, Holleman F, Soeters MR, Nieuwdorp M, Bergman JJGHM. A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon\u2011Like\u2011Peptide\u20111 Receptor Agonist in Type 2 Diabetes in a Pilot Study. Front Clin Diabetes Healthc. 2022;3:856661. https:\/\/doi.org\/10.3389\/fcdhc.2022.856661","DOI":"10.3389\/fcdhc.2022.856661"},{"key":"2023_CR18","doi-asserted-by":"publisher","unstructured":"Van Baar ACG, Devi\u00e8re J, Hopkins D, Crenier L, Holleman F, Galv\u00e3o Neto MP, Becerra P, Vignolo P, Rodriguez Grunert L, Mingrone G, Costamagna G, Nieuwdorp M, Guidone C, Haidry RJ, Hayee B, Magee C, Lopez\u2011Talavera JC, White K, Bhambhani V, Cozzi E, Rajagopalan H, Bergman JJGHM; Investigators of the REVITA\u20111 Study. Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA\u20111 Study). Diabetes Research and Clinical Practice. 2022;184:109194. https:\/\/doi.org\/10.1016\/j.diabres.2022.109194","DOI":"10.1016\/j.diabres.2022.109194"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02023-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:39:49Z","timestamp":1768552789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-025-02023-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02023-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this is a systematic review of already published literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as this is a systematic review no conent was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}